Sinopharm Group Co. Ltd. (OTCMKTS:SHTDY – Get Free Report) saw a significant decline in short interest during the month of August. As of August 31st, there was short interest totaling 1,929 shares, a decline of 87.4% from the August 15th total of 15,265 shares. Based on an average trading volume of 183,762 shares, the days-to-cover ratio is presently 0.0 days.
Sinopharm Group Stock Performance
Shares of OTCMKTS:SHTDY opened at $9.69 on Friday. Sinopharm Group has a 52-week low of $9.54 and a 52-week high of $14.87. The stock’s fifty day simple moving average is $10.60 and its 200-day simple moving average is $11.57.
About Sinopharm Group
Sinopharm Group Co, Ltd. (OTCMKTS:SHTDY) is one of China’s largest integrated healthcare companies and an indirect subsidiary of the state-owned China National Pharmaceutical Group Co, Ltd. The company operates through two primary segments—pharmaceutical distribution and retail pharmacy—offering comprehensive supply chain solutions that span procurement, storage, transportation and sales of medical products. With a broad portfolio that includes prescription drugs, over-the counter medicines, medical devices and consumables, Sinopharm serves hospitals, clinics, retail pharmacies and other healthcare institutions across mainland China.
In its distribution business, Sinopharm leverages an extensive logistics network, comprising hundreds of distribution centers and thousands of delivery vehicles, to ensure timely delivery of pharmaceuticals under stringent temperature-controlled conditions.
Featured Stories
- Five stocks we like better than Sinopharm Group
- Is Nike’s Index Demotion a Warning or a Buying Opportunity?
- American Eagle Goes on Sale: Is It Time to Buy?
- MarketBeat Week in Review – 09/07 – 09/11
- Block Makes a Federal Trust Bank Move That Could Reshape Its Fintech Model
Receive News & Ratings for Sinopharm Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sinopharm Group and related companies with MarketBeat.com's FREE daily email newsletter.
